Screening for preinvasive disease of the cervix, and detecting and mapping the lesions for treatment, are fundamental to programs for the prevention of cervical cancer. These will become even more important in women vaccinated against humanpapilloma viruses 16 and 18. Biophysical imaging technologies have considerable potential advantages in both screening for and mapping the lesions. This review describes the technologies that seem to have the greatest promise.